Sign in
8-K

Current Report

Emmaus Life Sciences, Inc. Filed Acc 0001615774-17-006767

Material agreement · Acquisition or sale completed · New debt or obligation · Executive or director change · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 2.03 Creation of a direct financial obligation
  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading s108189_8k.htm…